March 27, 2020
We have had an update from the MitoSENS team at the SENS Research Foundation about MitoMouse backer rewards which were due to ship at the end of last month. All the items have been ordered, however, we will not be able to physically ship anything until we are allowed into the building. Due to the...
March 09, 2020
Researchers from AgeX Therapeutics and other organizations have proved the feasibility of reprogramming banked cells derived from a supercentenarian. Their discovery portends exciting new possibilities for aging research. What is cellular reprogramming? Cellular reprogramming is the process of reverting mature, specialized cells into induced pluripotent stem cells (iPSCs), which can develop into any cell type...
March 07, 2020
We have had an update from the SENS Research Foundation team regarding donor gifts for the Mitomouse fundraiser. The Mitomouse team report that they have finalized the orders for the t-shirts and tote bags today and they printers will now begin production. Once the foundation recieves the finished items they will shipped out to backers,...
March 06, 2020
New research suggests that the very immune cells that protect our brain can eventually start attacking it due to chronic systemic inflammation, something that is typically present in older people. The blood-brain barrier The blood-brain barrier (BBB) surrounds most of the blood vessels in the brain and forms a protective barrier between the bloodstream and...
March 04, 2020
A team of researchers led by Dr. Jeffrey Millman at Washington University may be a step closer to a potential solution to diabetes, according to the results of a new study in which replacement beta cells were given to mice. What is diabetes? Diabetes is a disease that occurs when blood glucose levels are constantly...
March 03, 2020
Researchers from the Universities of Harvard and Tel Aviv have succeeded in linking up to 10 "organs-on-a-chip" via an analog of human vasculature. The invention allows for in vitro testing of drug toxicity and action, taking us one step closer to automated clinical trials and the development of personalized drugs. Chipping away at trial duration...